Considering Baseline Risk When Prescribing Pharmacologic Treatment

JAMA Internal Medicine - United States
doi 10.1001/jamainternmed.2013.286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

The Pharmacologic Treatment of Depression

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
1998English

Pharmacologic Treatment of Eating Disorders

Canadian Journal of Psychiatry
PsychiatryMental Health
2002English

Physician Communication When Prescribing New Medications

Archives of Internal Medicine
2006English

3. COPD: Non-Pharmacologic Treatment

Internal Medicine
Internal MedicineMedicine
2007English

Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy

Obstetrics and Gynecology
GynecologyObstetrics
2011English

Pharmacologic Treatment of Pediatric Anxiety Disorders

2019English

Ten Simple Rules When Considering Retirement

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2018English

When Neurologist and Patient Disagree on Reasonable Risk: New Challenges in Prescribing for Patients With Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2011English

Pharmacologic Treatment of Anxiety Disorders in Parkinson Disease

American Journal of Geriatric Psychiatry
PsychiatryGerontologyGeriatricsMental Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy